Bio/pharmaceutical
Jul 12, 2011 at 22:41 | Source: PTI
Jan 27, 2009 at 17:21 | Source: CNBC-TV18
Nov 28, 2008 at 12:21
Oct 29, 2008 at 13:29
Jul 23, 2008 at 18:50
Photos »
/ 
News across the web »
$350-mn Pfizer-Biocon pact offBiocon stock hits 52-week low, company still likely to get $150-170 mn
Mar 14, 2012 at 04:46 | Source: Business Standard
Mar 01, 2012 at 13:31 | Source: The Hindu BusinessLine
Interact & exchange stock tips & market info »
Related News »
BEIJING, May 21, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP - News) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and ...
May 21, 2012 at 11:58 | Source: Yahoo Finance
1Q12 Revenue was RMB60.3 Million ($9.6 Million) 1Q12 Net Income was RMB0.7 Million ($0.1 Million) Mr. Baizhong Xue, the Company's Chairman and Chief Executive Officer, stated, "We are pleased to announce financial results for the first quarter ...
May 24, 2012 at 11:54 | Source: Yahoo Finance
May 23, 2012 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Pharmaceuticals industry with the lowest price to sales per share ratios. Often companies with the lowest ratio present the greatest value to investors ...
May 23, 2012 at 11:05 | Source: TMCnet
November Research Group, LLC, (http://www.novemberresearch.com), a global leader of professional services, providing drug and medical device safety consulting and software solutions for pharmaceutical and life sciences organizations continues to attract ...
May 23, 2012 at 06:55 | Source: PRWeb
According to a recent report, the biopharma cold chain logistics market reached $5.9BN in 2009 and is expected to hit $6.9BN in 2012, with the Asian market contributing $1.2BN in 2009 and heading for $2.2BN in 2015. Growth in cold chain spending in Asia is ...
May 24, 2012 at 00:56 | Source: PharmiWeb
Mr. Weibing Lu, Chairman and Chief Executive Officer of Skystar, commented, "Management is pleased to announce a strong start for Skystar closing the first quarter of the new fiscal year on pace to meet fiscal guidance. While 2012 marks a transitional year ...
May 16, 2012 at 08:58 | Source: Market Wire
Now, a study by a pharmaceutical industry group concludes that bio-pharmaceutical companies are helping support 81,000 jobs in Maryland. The study says Maryland has hosted 3,500 clinical drug trials since 1999. Most of the trials take place in Baltimore ...
May 20, 2012 at 09:43 | Source: FederalNewsRadio.com
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and ...
May 23, 2012 at 07:59 | Source: PR Newswire
It is an emerging bio-pharmaceutical company focused on the development of its pipeline of compounds targeting areas of unmet medical need. Our flagship compound, Kevetrin™, is an anti-cancer drug which has demonstrated the ability in pre ...
May 21, 2012 at 13:09 | Source: msnbc.com
The stock closed at $2.63 with 17,126 shares moving. The stock traded in a range of $2.30 to $2.85. SKYSTAR BIO-PHARMACEUTICAL COMPANY (SKBI) rose 6.8% to close at $2.67, cross its 50-day moving average of $2.56 and 200-day moving average of $2.66.
May 18, 2012 at 20:01 | Source: FOXBusiness